Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

Micro-CT helps identify suitable areas for surgical procedures based on blood vessel distribution in hypospadias-affected rats.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Androgen signaling reduces Wnt activity, affecting prostate stem cell growth.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Hair loss can be an early sign of prostate enlargement.

Endurance exercise may help BPH by lowering hormones and inflammation.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

BPH treatments are improving with personalized medicine and better surgical options.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Targeting FGF5 could help treat prostate cancer.

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Men with BPH should discuss potential sexual side effects with doctors before treatment, as some treatments can affect ejaculation.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.